MSCopilot® digital biomarkers obtained in a real-world setting correlated with their clinical counterparts in the MS-DETECT study

At the SIN Congress in Pisa, Italy, in September 2025, we presented interim data from MS-DETECT, a prospective longitudinal study evaluating the performance of MSCopilot® software in real life. MSCopilot® scores correlate significantly with traditional clinical scores, including the MSFC-4 (the Multiple Sclerosis Functional Composite with its 4 Components), demonstrating promising potential in the early detection of disease progression. The tool, designed for home assessment, measures walking, dexterity, cognitive function, and visual acuity.

Share